ONE-WAYDated event · through FY2026

Japanese joint development and licensing agreement for HB2198 (KRP-A225) with HingeBio

An individual contract theme involving the development and commercialization in Japan of HB2198 (KRP-A225), introduced from HingeBio, for SLE and other conditions. It includes an upfront payment, development and sales milestones, royalties, and a supply price.

Companies1How many companies write about this.

Threads1One company can carry more than one thread here.

PeriodFY2026-H1 →Last written FY2026

Directionhelps1 helps · 0 hurts · 0 flat